Safety Assessment and Probiotic Potential of a Novel Species Lactobacillus xujianguonis
Nutrients · 04.11.2025 · 17 (21) · 3474
DOI: 10.3390/nu17213474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 04.11.2025. Verfasst von Xiaoying Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Probiotics, Lactobacillus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Academy of Engineering Regional Cooperation Projects.
Abstract (Originalsprache)
Background
Some lactobacilli strains have been documented to cause bacteremia and sepsis in immunocompromised or critically ill hospitalized patients, challenging the universally presumed safety of lactobacilli. Therefore, strain-specific risk assessments are required for the use of Lactobacillus as a probiotic. Lactobacillus xujianguonis, a novel Lactobacillus species isolated from Marmota himalayana, has probiotic potential but lacks safety data.
Objective
To evaluate the preclinical safety of L. xujianguonis for food-grade use.
Methods
Systematic safety assessment includes in vitro studies and oral toxicity studies. In vitro studies encompassed gastrointestinal tolerance, auto-aggregation and pathogen inhibition, antibiotic susceptibility, and hemolysis/gelatinase activity assays. Oral toxicity studies contained acute single-dose and repeated-dose 28-day oral toxicity studies in mice based on the OECD toxicity study guidelines.
Results
L. xujianguonis strains HT111-2 and 06-2 demonstrated certain probiotic traits, including high acid/bile tolerance, strong auto-aggregation, and antimicrobial activity against common human gastrointestinal pathogens. In vitro safety assessments showed susceptibility to nine antibiotics and absence of hemolytic/gelatinase activity. Acute oral exposure (1 × 1011 CFU/kg) induced no mortality, clinical abnormalities, or organ toxicity. Subchronic 28-day administration (multiple doses) showed absence of adverse clinical signs with body weight stability and no hematological, biochemical, or histopathological deviations in C57BL/6 mice. Inflammatory and immunological markers remained unaffected. Histological staining results and transcriptional level validation revealed no evidence of intestinal tissue damage.
Conclusions
This study provides preliminary evidence of the safety of L. xujianguonis, supporting its advancement to functional research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Nanjing Medical University, Nanjing 211166, China.
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102…
- School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney 2052, NSW, Australia.
- Hebei Key Laboratory of Intractable Pathogens, Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang 050010, China.
- Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan 030001, China.
ORCID-Profile: Ruiting Lan
Förderung
- China Academy of Engineering Regional Cooperation Projects
Zitieren
APA
Lin, X., Zhou, X., Lu, Y., Yuan, Z., Lan, R., Du, Y., Liu, L., & Xu, J. (2025). Safety Assessment and Probiotic Potential of a Novel Species Lactobacillus xujianguonis. Nutrients, 17(21), 3474. https://doi.org/10.3390/nu17213474
Vancouver
Lin X, Zhou X, Lu Y, Yuan Z, Lan R, Du Y, et al. Safety Assessment and Probiotic Potential of a Novel Species Lactobacillus xujianguonis. Nutrients. 2025;17(21):3474. doi:10.3390/nu17213474
BibTeX
@article{Lin2025,
author = {Lin, Xiaoying and Zhou, Xiaohui and Lu, Yao and Yuan, Zheyu and Lan, Ruiting and Du, Ying and Liu, Liyun and Xu, Jianguo},
title = {Safety Assessment and Probiotic Potential of a Novel Species Lactobacillus xujianguonis},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {21},
pages = {3474},
doi = {10.3390/nu17213474}
}
EUVIMED